Compounds > difloxacin
Page last updated: 2024-08-24

difloxacin and Bacterial Infections

difloxacin has been researched along with Bacterial Infections in 4 studies

*Bacterial Infections: Infections by bacteria, general or unspecified. [MeSH]

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19904 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chu, DT; Fernandes, PB; Maleczka, RE; Nordeen, CW; Pernet, AG1
Chu, DT; Claiborne, AK; Fernandes, PB; Maleczka, RE; Nordeen, CW; Pernet, AG; Pihuleac, E1
Bodey, GP; Ho, DH; LeBlanc, B; Rolston, KV1
Bower, RR; Chu, DT; Fernandes, PB; Jarvis, KP; Ramer, NR; Shipkowitz, N1

Other Studies

4 other study(ies) available for difloxacin and Bacterial Infections

ArticleYear
Synthesis and structure-activity relationship of 1-aryl-6,8-difluoroquinolone antibacterial agents.
    Journal of medicinal chemistry, 1987, Volume: 30, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Female; Fluorine; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mice; Microbial Sensitivity Tests; Quinolines; Spectrophotometry, Infrared; Structure-Activity Relationship

1987
Synthesis and structure-activity relationships of novel arylfluoroquinolone antibacterial agents.
    Journal of medicinal chemistry, 1985, Volume: 28, Issue:11

    Topics: Acinetobacter; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Chemical Phenomena; Chemistry; Ciprofloxacin; Enterobacter; Escherichia coli; Female; Fluorine; Fluoroquinolones; Klebsiella pneumoniae; Mice; Norfloxacin; Pefloxacin; Piperazines; Pseudomonas aeruginosa; Quinolines; Staphylococcus; Streptococcus; Structure-Activity Relationship

1985
In vitro evaluation of S-25930 and S-25932, two new quinolones, against aerobic gram-negative isolates from cancer patients.
    Antimicrobial agents and chemotherapy, 1987, Volume: 31, Issue:1

    Topics: Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Enoxacin; Fluoroquinolones; Gram-Negative Bacteria; Humans; Naphthyridines; Neoplasms; Quinolizines

1987
In vivo evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.
    Antimicrobial agents and chemotherapy, 1986, Volume: 29, Issue:2

    Topics: Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Fluoroquinolones; Half-Life; Immunosuppression Therapy; Klebsiella Infections; Mice; Norfloxacin; Piperazines; Proteus Infections; Pseudomonas Infections; Pyelonephritis; Quinolines; Salmonella Infections, Animal; Staphylococcal Infections; Streptococcal Infections

1986